Core Viewpoint - Quantum BioPharma Ltd. addresses misinformation regarding its name and potential reverse takeover with Unbuzzd Wellness Inc., clarifying that it has not changed its name and is not involved in any RTO transaction with Unbuzzd [1][2] Company Overview - Quantum BioPharma is a biopharmaceutical company focused on innovative assets and biotech solutions for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders [6] - The company retains a 20.11% ownership stake in Unbuzzd Wellness Inc. as of March 31, 2025, and has developed the product unbuzzd™, which aids in alcohol metabolism [6] Financial Agreements - Quantum BioPharma is the largest shareholder and debt holder of Unbuzzd Wellness Inc., receiving a 7% royalty on revenue until a total of 1.3 million at a 10% annual interest rate, secured for three years [3] Leadership and Expertise - Unbuzzd Wellness Inc. is led by CEO John Duffy, who has a strong background in the beverage industry, and is supported by Gerry David, former CEO of Celsius Holdings, Inc. [4] Product Information - Unbuzzd is a scientifically-backed product that accelerates alcohol metabolism and reduces hangover symptoms, supported by clinical trials [9] - The product is available in various formats and aims to appeal to consumers looking for responsible drinking solutions [8][9] Debt Settlement - Quantum BioPharma has authorized a debt settlement totaling USD $20,930 with Class B Shares, expected to be completed in early June 2025 [5]
Quantum BioPharma Clarifies It Has Not Changed Its Name